Liquid drug medical device

Information

  • Patent Grant
  • 8021325
  • Patent Number
    8,021,325
  • Date Filed
    Wednesday, April 6, 2005
    19 years ago
  • Date Issued
    Tuesday, September 20, 2011
    13 years ago
Abstract
The present invention relates to liquid drug medical devices for enabling the administration of liquid drugs, and also a needle shield removal device for safely removing needle shields.
Description
BACKGROUND OF THE INVENTION

The invention pertains to liquid drug medical devices, and needle shield removal devices.


Commonly owned PCT International Application No. PCT/US96/03732 published under PCT International Publication No. WO96/29113 illustrates and describes fluid control devices for administration of liquid drugs. The fluid control devices include inter alia fluid control devices now commercially available from Medimop Medical Projects Ltd, Ra'anana, Israel (www.medimop.com), under the registered trademark MIXJECT®. The MIXJECT® fluid control devices have a longitudinal axis, and include a base member with a syringe port for receiving a syringe, and a dispensing port in the form of a plastic cannula, a needle, and the like. The base member rotatably supports a flow control member with a manually rotatable vial adapter coupled thereto for rotating same between a first flow control position for connecting the syringe port with a vial received within the vial adapter, and a second flow control position for connecting the syringe port with the dispensing port (see WO96/29113's FIGS. 1-19). The vial adapter is preferably screw threadingly detachable from the base member at the second flow control position along a line of detachment transversely directed to the fluid control device's longitudinal axis (see WO96/29113's FIGS. 11-16).


Conventional needles have a female Luer connector for sealingly fitting on conventional syringes having a male Luer connector. Some syringes are made with a syringe tip having a distal end with a projecting lip to positively prevent a conventional needle being mounted thereon. However, such syringes are undesirably precluded from being used with other transfer devices having a female Luer connector, for example, vial adapters commercially available from Medimop Medical Projects Ltd, Ra'anana, Israel. Moreover, conventional needles are often supplied with needle shields for preventing needle sticks injuries. Needle shields are friction fitted on needles and are often difficult to remove in part due to their small dimensions which render them difficult to grasp. Exemplary needle shield removal devices are illustrated and described in inter alia EP 0 518 397 entitled “Device for the removal and replacement of a needle shield”, WO 02/09797 entitled “Pen Needle and Safety Shield System”, and WO2003/051423 entitled “Needle Closure System Removal Device”.


BRIEF SUMMARY OF THE INVENTION

In accordance with a first aspect of the present invention, there is provided a liquid drug medical device for use with a source of physiological solution and a medicinal vessel for administration of a liquid drug, the device having a longitudinal axis and comprising:

    • (a) a body member having a first port for fluid connection with the source of physiological solution;
    • (b) a flow control member rotatably mounted in said body member about an axis of rotation co-directional with the longitudinal axis, and having a first major flow duct and a second major flow duct substantially parallel to and non-coaxial with said axis of rotation and respectively terminating at a second port, and a third port for administering the liquid drug; and
    • (c) a manually rotatable adapter having a fluid conduit member with a proximal end in flow communication with said second port and a distal end extending into the medicinal vessel on its attachment to said adapter, and coupled to said flow control member for rotating same between a first flow control position for connecting said first port with said second port, and a second flow control position for connecting said first port with said third port.


Liquid drug medical devices of the present invention preferably include an adapter detachable along a line of detachment co-directional with the drug medical device's longitudinal axis thereby affording a more ergonomic inline detachment than the hitherto aforementioned MIXJECT® fluid control devices with transversely directed lines of detachment. Such liquid drug medical devices with detachable adapters also lend themselves to more compact devices affording improved handling, and preferably include drug dispensers, for example, a built-in needle, an atomizer, and the like, in fluid connection with their third ports suitable for self-administration of a liquid drug. Different adapters can be designed suitable for use with different medicinal vessels including inter alia vials, ampoules, and the like.


In accordance with a second aspect of the present invention, there is provided a liquid drug medical device for use with a syringe having a syringe tip with a distal end having a projecting lip, and a medicinal vial with a rubber stopper, the device comprising an adapter for snap fitting onto the vial and including a hollow puncturing member for puncturing the rubber stopper on snap fitting said adapter on the vial, and an elastomer tubing in flow communication with said puncturing member and having a distal end capable of being sealingly stretched over the syringe's projecting lip for effecting fluid communication between the syringe and the medicinal vial. Thus, the liquid drug transfer device is adapted for convenient use with syringes prevented from having conventional needles with a female Luer connector slidingly mounted thereon.


In accordance with a third aspect of the present invention, there is provided a needle shield removal device for use with a liquid drug medical device with a needle protected by a needle shield, the needle including a hub with a flange rim, and a needle stick, the needle shield removal device comprising:

    • (a) a base member including at least two spaced apart support legs terminating at end faces; and
    • (b) a needle shield release member including a pair of oppositely directed finger supports, and at least two spaced apart clamping legs interposed between said at least two spaced apart support legs and terminating at needle shield grips for bearing against the needle's flange rim for slidingly removing the needle shield from the needle,
    • said needle shield release member being slidingly displaceable along said base member from an initial outwardly biased position in which said needle shield grips are substantially flush with said end faces and a retracted position in which said needle shield grips are inwardly disposed relative to said end faces,
    • the needle shield removal device being slidingly mounted on the liquid drug medical device for enveloping the needle shield therewithin whereupon the needle shield release member is positively urged to said retracted position for entraining the needle shield therewith thereby safely exposing the needle stick.





BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS

In order to understand the invention and to see how it can be carried out in practice, preferred embodiments will now be described, by way of non-limiting examples only, with reference to the accompanying drawings in which similar parts are likewise numbered, and in which:


In the drawings:



FIG. 1 is a pictorial view of a liquid drug medical device in accordance with the first aspect of the present invention, a pre-filled syringe, a vial containing a drug concentrate, and an empty packaging previously housing the liquid drug medical device;



FIG. 2 is a top view of FIG. 1's packaging opened but prior to removal of the liquid drug medical device;



FIG. 3 is an exploded view of the liquid drug medical device of FIG. 1 having a built-in needle for administering a liquid drug to a subject;



FIGS. 4A and 4B are cross sections respectively along lines A-A and B-B in FIG. 2 of FIG. 1's liquid drug medical device in its set-up position;



FIGS. 5A-5F show the use of FIG. 1's liquid drug medical device for preparing a liquid drug ready for administration to a subject;



FIG. 6 is a cross section of a second preferred embodiment of a liquid drug medical device of the present invention including an atomizer;



FIG. 7 is a cross section of a third preferred embodiment of a liquid drug medical device of the present invention including a drug dispenser port;



FIG. 8 is a perspective view of a liquid drug medical device in accordance with the second aspect of the present invention, a syringe with a syringe tip with a protruding lip, and a vial containing a drug concentrate;



FIG. 9 is a longitudinal cross section of a first embodiment of FIG. 8's liquid drug medical device along line C-C in FIG. 8;



FIG. 10 is a longitudinal cross section of a second embodiment of FIG. 8's liquid drug medical device along line C-C in FIG. 8;



FIG. 11 is a longitudinal cross section of a third embodiment of FIG. 8's liquid drug medical device along line C-C in FIG. 8;



FIG. 12 is a perspective view of a syringe with a protected needle and a needle shield removal device in accordance with the third aspect of the present invention;



FIG. 13 is an exploded view of the needle shield removal device of FIG. 12;



FIG. 14 is a longitudinal cross section of the needle shield removal device of FIG. 12 in its first operative state;



FIG. 15 is a longitudinal cross section of the needle shield removal device of FIG. 12 in its second operative state;



FIG. 16 is a longitudinal cross section showing placement of the needle shield removal device on a syringe with a protected needle;



FIG. 17 is a longitudinal cross section showing detachment of the needle shield from the syringe to expose its needle; and



FIG. 18 is a longitudinal cross section showing removal of the needle shield removal device together with the needle from the syringe.





DETAILED DESCRIPTION OF THE INVENTION


FIG. 1 shows a liquid drug medical device 10 for use with a typically pre-filled syringe 11 having a clockwise threaded male Luer lock connector 12, and a vial 13 having a rubber stopper 14 and containing a dry powder drug concentrate 16 but could equally contain a liquid drug concentrate. The liquid drug medical device 10 is designed to reconstitute the drug concentrate in the vial 13 for aspiration into the syringe 11 ready for typically self-administration. The liquid drug medical device 10 is typically packaged in a sealed sterile non-pyrogenic packaging 17 including a transparent plastic casing 18 with a peel off cover 19 shown partially removed for enabling removal of the liquid drug medical device 10. The casing 18 has a longitudinally directed stopper 21 for stopping rotation of the liquid drug medical device 10 at a set-up position pursuant to screwing the syringe 11 onto the liquid drug medical device 10 (see FIG. 2).



FIGS. 3 and 4 show that the liquid drug medical device 10 has a longitudinal axis 22, and includes a base member 23 having a first port 24, a flow control member 26 having a second port 27 and a third port 28 provided with a needle stick 29, and a vial adapter 31 (constituting an adapter) removably attachable to the base member 23. The first port 24 has a clockwise threaded female Luer connector 32 for screw threadingly receiving the syringe's clockwise threaded male Luer connector 12 in a clockwise direction. The base member 23 has a chamber 33 with an annular recess 34 for snap fit receiving an annular flange 36 formed on the flow control member 26 whereby the flow control member 26 is rotatably supported in the chamber 33 about an axis of rotation 37 co-axial with the longitudinal axis 22. The first port 24 is in fluid communication with the chamber 33 via a radially directed bore 38 perpendicular to the axis of rotation 37. The base member 23 has a pair of laterally protruding members 39A and 39B at its proximal end for stopping against the stopper 21, and a pair of half turn screw threads 41A and 41B for enabling screw thread engagement of the vial adapter 31 thereonto.


The vial adapter 31 has an elongated stem 42 including a fluid conduit member 43 with a proximal end 43A in fluid communication with the second port 27 on attachment of the vial adapter 31 on the base member 23, and a pointed distal end 43B for puncturing the vial's rubber stopper 14 on its positive insertion into the vial adapter 31 and extending slightly therebeyond so that on inverting the vial its nearly entire contents can be aspirated thereinto (see FIG. 5E). The stem 42 includes a bore 44 parallel to the fluid conduit member 43 and largely co-extensive therewith for accommodating the needle stick 29 therein on attachment on the vial adapter 31 on the body member 23. The stem 42 has a proximal end 42A with a pair of laterally protruding arms 46A and 46B for screw threading onto the pair of half turn screw threads 41A and 41B, and for stopping against the stopper 21. The screw threads 41A and 41B are screw threaded in a counter direction to the male and female threaded Luer connectors 12 and 32 such that screwing the syringe 11 onto the base member 23 causes the vial adapter 31 to be fully threaded onto the base member 23, and rotation of the liquid drug medical device 10 in the casing 18 such until both the base member's member 39A and the vial adapter's arm 46A abut against the stopper 21 thereby priming the liquid drug medical device 10 into its set-up position. The proximal end 42A is formed with a slot 47 for receiving a downward depending key 48 formed on the underside of the flow control member 26 thereby coupling the vial adapter 31 to the flow control member 26 such that manual rotation of the vial adapter 31 correspondingly rotates the flow control member 26.


The second port 27 is in flow communication with the first port 24 via a first major flow duct 48 parallel to and non-coaxial with the axis of rotation 37 and a first minor flow duct 49 in registration with the bore 38 in a first flow control position of the flow control member 26 in the set-up position of the liquid drug medical device 10 (see FIG. 4A). The third port 28 is in flow communication with the first port 24 via a second major flow duct 51 parallel to and non-coaxial with the axis of rotation 37 and a second minor flow duct 52 in registration with the bore 38 in a second flow control position of the flow control member 26 when the vial adapter 31 is rotated through a half turn ready for axial detachment from the base member 23 along a line of detachment co-directional with the longitudinal axis 22 (see FIG. 5E).


The use of the liquid drug medical device 10 is now described with reference to FIGS. 5A-5F:


The peel off cover 19 is removed from the casing 18 and a pre-filled syringe 11 is screw threaded clockwise onto the female Luer connector 32 (see FIG. 5A). The liquid drug medical device 10 may initially rotate within the casing 18 depending on its initial placement therein but stops rotating when primed into its set-up position. The liquid drug medical device 10 is withdrawn from the casing 18 and the vial 13 is positively inserted into the vial adapter 31 such that the fluid conduit member 43 punctures its rubber stopper 14 (see FIG. 5B). The syringe's contents are injected into the vial 13 (see FIG. 5C), and the entire assembly including the liquid drug medical device 10, the now empty syringe 11, and the vial 13 is shaken to reconstitute the vial's dry powder drug concentrate. The entire assembly is inverted and the syringe 11 is aspirated to draw the reconstituted liquid drug thereinto (see FIG. 5D). The vial adapter 31 is rotated through a half turn counterclockwise to rotate the flow control member 26 into its second flow control position for connecting the syringe 11 with the needle stick 29, and simultaneously enabling axial detachment of the vial adapter 31 with the spent vial 13 from the base member 23 (see FIG. 5E). The liquid drug medical device 10 is now ready for administering the reconstituted liquid drug via the still dry needle stick 29 to a subject (see FIG. 5F).



FIG. 6 shows a liquid drug medical device 61 having a flow control member 62 provided with an atomizer 63.



FIG. 7 shows a liquid drug medical device 66 having a flow control member 67 provided with a drug dispenser port 68.



FIG. 8 shows a liquid drug transfer device 100 for use with a syringe 101 having a syringe tip 102 with a distal tip 103 having a projecting lip 104 for blocking the sliding mounting of a conventional needle with a female Luer connector thereon, and a vial 106 having a rubber stopper 107 and containing a dry powder drug concentrate 108 but could equally contain a liquid drug concentrate. The liquid drug transfer device 100 includes a vial adapter 111 with a top wall 112, a resiliently deformable slitted skirt 113 for snap fitting onto the vial 106, and a hollow puncturing member 114 (see FIGS. 9-11) for puncturing the vial's rubber stopper 107, and an elastomer tubing 116 in flow communication with the puncturing member 114 and having a distal end 117 for sealingly fitting over the syringe's projecting lip 104 for enabling flow communication between the syringe 101 and the vial 106. The tubing 116 typically has a length L=10-20 mm and a nominal internal diameter D1=3-4 mm which can be readily stretched to at least 6 mm to sealingly fit over the projecting lip's diameter D2>D1 without tearing, ripping, and the like. The tubing 116 is preferably formed from one of the following substances: PVC, silicone, rubber, and the like.



FIG. 9 shows a liquid drug transfer device 100 including a vial adapter 111 with an upright nipple 118 having tubing 116 press fitted or bonded thereon. FIG. 10 shows a liquid drug transfer device 100 having a vial adapter 111 over molded (or otherwise known as insert molded) around the tubing 116. FIG. 11 shows a liquid drug transfer device 100 manufactured using two material injection molding, namely, the vial adapter 111 and the tubing 116 are made in one and the same mold.



FIG. 13 shows a needle shield removal device 200 for use with a liquid drug medical device 201 fitted with a needle 202 protected by a needle shield 203. The liquid drug medical device 201 can be in the form of a syringe, a MIXJECT® fluid control device commercially available from Medimop Medical Projects Ltd, Ra'anana, Israel, and the like. The liquid drug medical device 201 includes a male Luer lock connector 204 with a distal annular end face 206. The needle 202 includes a hub 207 with a ribbed surface 208 and a flange rim 209 for screw insertion into the male Luer lock connector 204, and a needle stick 211. The needle shield 203 includes a flanged rim 212 and is designed to snap fit onto the ribbed surface 208 to shield the needle stick 211 whereupon the flanged rim 212 is separated from the end face 206 by an about 1-2 mm gap. The needle shield removal device 200 is designed to positively slide the needle shield 203 by an about 1 mm-2 mm stroke sufficient to release the needle shield 203 from the liquid drug medical device 201, thereby safely and conveniently exposing the needle stick 211.



FIG. 14 shows the needle shield removal device 200 includes a triple-legged base member 214, a compression spring 216, and a triple legged needle shield release member 217. The base member 214 has a cap 218 with a top wall 219, an outer wall 221 with an undercut 222, and an inner wall 223 defining a tubular cavity 224 with the outer wall 221 for receiving the compression spring 216. The inner wall 223 is formed with three support legs 226 equidistanced therearound, and each occupying an arc angle of about 60°. The support legs 226 terminate in flat end faces 227 for abutment against the end face 206 on slidingly mounting the needle shield removal device 200 onto the liquid drug medical device 201 with the protected needle 202.


The needle shield release member 217 has an annular head 228 formed with a retaining tab 229 for stopping against the undercut 222 for retaining the needle shield release member 217 in the base member 214 on snap fit insertion of the head 228 into the tubular cavity 226. The head 228 has a pair of oppositely directed laterally extending finger supports 231 for enabling a compression force to be applied to the compression spring 16 for enabling the needle shield release member 217 to be positively urged into the base member 214 from an outward spring biased position (see FIG. 15) to an inward hand compressed position (see FIG. 16). The head 228 is formed with three needle shield clamping legs 232 equidistanced therearound and intended to be interposed between adjacent support legs 226 on assembly of the needle shield removal device 213. The needle shield release legs 232 also each occupy an arc angle of about 60° similar to the support legs 226 such that the needle shield removal device 213 circumscribes a needle shield 203 on its sliding mounting the liquid drug medical device 201 with the protected needle 202. The needle shield clamping legs 232 terminate in inwardly directed needle shield grips 233 flush with the end faces 227 in the outward spring biased position (see FIG. 14) and are intended for bearing against the needle shield's flange rim 212 facing the end face 206 on application of the compression force to positively draw the needle shield release member 217 into the base member 213.


The use of the needle shield removal device 200 is as follows:


The user holds the liquid drug medical device 201 with the protected needle 202 in one hand and the needle shield removal device 200 in his other hand. The user slidingly mounts the needle shield removal device 200 onto the liquid drug medical device 201 until the needle shield grips 233 snap fit over the flange rim 212 and the end faces 227 abut against the end face 206 (see FIG. 16). The user places his thumb on the top wall 219 and his digit finger and middle finger against the undersides of the finger supports 231 so that he can apply a compressive force to urge the needle shield release member 217 into the base member 214. The needle shield release member 217 by virtue of its needle shield grips 233 bearing against the needle shield's flange rim 212 entrains the needle shield 203 therewith, thereby safely and conveniently exposing the needle stick 211 for injection purposes. The user disposes of the spent liquid drug medical device 200 with its exposed needle stick 211 in a sharps container.


While the invention has been described with respect to a limited number of embodiments, it will be appreciated that many variations, modifications, and other applications of the invention can be made within the scope of the appended claims.

Claims
  • 1. A liquid drug medical device for use with a source of physiological solution and a medicinal vessel for administration of a liquid drug, the device having a longitudinal axis, and comprising: (a) a body member having a first port for fluid connection with the source of physiological solution, said first port being co-directional with the longitudinal axis;(b) a flow control member rotatably mounted in said body member about an axis of rotation, and having a first major flow duct and a second major flow duct respectively terminating at a second port, and a third port for administering the liquid drug; and(c) a manually rotatable vial adapter for receiving the medicinal vessel, the manually rotatable vial adapter having a fluid conduit member with a proximal end in flow communication with said second port and a distal end adapted to extend into the medicinal vessel on its attachment to said vial adapter, and coupled to said flow control member for rotating the flow control member between a first flow control position which connects said first port with said second port, and a second flow control position which connects said first port with said third port,said axis of rotation is co-directional with the longitudinal axis, and said first major flow duct and said second major flow duct are both substantially parallel to and non-coaxial with said axis of rotation and wherein said distal end of the fluid conduit member extends into a recess in the vial adapter.
  • 2. The device according to claim 1 wherein said vial adapter is detachable from said body member at said second flow control position along a line of detachment co-directional with the longitudinal axis.
  • 3. The device according to claim 2 wherein said first port has a screw thread for screw threadingly receiving the source of physiological solution in one direction and said adaptor screw threadingly detaches from said body member in an opposite direction.
  • 4. The device according to claim 3 wherein the device is packaged in a sterile packaging and said body member has at least one laterally protruding member for stopping against an internal longitudinally directed stopper on the inside of the sterile packaging on screw threading the source of physiological solution into said first port whereupon said flow control member is urged into said first flow control position.
  • 5. The device according to claim 4 wherein said vial adapter has a stem including said fluid conduit member and a bore parallel thereto and co-extensive therewith for accommodating a drug dispenser coupled to said third port.
  • 6. The device according to claim 5 wherein said third port is fitted with a needle stick.
  • 7. The device according to claim 5 wherein said third port is fitted with an atomizer.
Priority Claims (1)
Number Date Country Kind
161660 Apr 2004 IL national
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a Section 371 of International Application No. PCT/IL2005/00376, filed Apr. 6, 2005, which was published in the English language on Nov. 10, 2005, under International Publication No. WO 2005/105014 A2, which claims priority to U.S. Provisional Application Nos. 60/587,550, filed Jul. 14, 2004 and 60/589,568, filed Jul. 21, 2004, the disclosures of which are incorporated herein by reference in their entirety.

PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/IL2005/000376 4/6/2005 WO 00 10/27/2006
Publishing Document Publishing Date Country Kind
WO2005/105014 11/10/2005 WO A
US Referenced Citations (300)
Number Name Date Kind
62333 Holl Feb 1867 A
1704817 Ayers Mar 1929 A
1930944 Schmitz, Jr. Oct 1933 A
2326490 Perelson Aug 1943 A
2931668 Baley Apr 1960 A
2968497 Treleman Jan 1961 A
3059643 Barton Oct 1962 A
D198499 Harautuneian Jun 1964 S
3484849 Huebner et al. Dec 1969 A
3618637 Santomieri Nov 1971 A
3757981 Harris, Sr. et al. Sep 1973 A
3826261 Killinger Jul 1974 A
3885607 Peltier May 1975 A
3957052 Topham May 1976 A
3977555 Larson Aug 1976 A
3993063 Larrabee Nov 1976 A
4020839 Klapp May 1977 A
4051852 Villari Oct 1977 A
4109670 Slagel Aug 1978 A
4187848 Taylor Feb 1980 A
4210173 Choksi et al. Jul 1980 A
D257286 Folkman Oct 1980 S
4253501 Ogle Mar 1981 A
4296786 Brignola Oct 1981 A
4314586 Folkman Feb 1982 A
D267199 Koenig Dec 1982 S
D271421 Fetterman Nov 1983 S
4434823 Hudspith Mar 1984 A
4475915 Sloane Oct 1984 A
4493348 Lemmons Jan 1985 A
D280018 Scott Aug 1985 S
4532969 Kwaan Aug 1985 A
4564054 Gustavsson Jan 1986 A
4576211 Valentini et al. Mar 1986 A
4588396 Stroebel et al. May 1986 A
4588403 Weiss et al. May 1986 A
D284603 Loignon Jul 1986 S
4604093 Brown et al. Aug 1986 A
4607671 Aalto et al. Aug 1986 A
4614437 Buehler Sep 1986 A
4638975 Iuchi et al. Jan 1987 A
4639019 Mittleman Jan 1987 A
4667927 Oscarsson May 1987 A
4676530 Nordgren et al. Jun 1987 A
4697622 Swift et al. Oct 1987 A
4721133 Sundblom Jan 1988 A
4729401 Raines Mar 1988 A
4743229 Chu May 1988 A
4743243 Vaillancourt May 1988 A
4758235 Tu Jul 1988 A
4759756 Forman et al. Jul 1988 A
4778447 Velde et al. Oct 1988 A
4787898 Raines Nov 1988 A
4834152 Howson et al. May 1989 A
4865592 Rycroft Sep 1989 A
4909290 Coccia Mar 1990 A
4967797 Manska Nov 1990 A
D314050 Sone Jan 1991 S
4997430 Van der Heiden et al. Mar 1991 A
5035686 Crittenden et al. Jul 1991 A
5045066 Scheuble et al. Sep 1991 A
5049129 Zdeb et al. Sep 1991 A
5053015 Gross Oct 1991 A
5061248 Sacco Oct 1991 A
5088996 Kopfer et al. Feb 1992 A
5096575 Cosack Mar 1992 A
5104387 Pokorney et al. Apr 1992 A
5113904 Aslanian May 1992 A
5122124 Novacek et al. Jun 1992 A
5125908 Cohen Jun 1992 A
5171230 Eland et al. Dec 1992 A
5201705 Berglund et al. Apr 1993 A
5201717 Wyatt et al. Apr 1993 A
5203771 Melker et al. Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211638 Dudar et al. May 1993 A
5232109 Tirrell et al. Aug 1993 A
5247972 Tetreault Sep 1993 A
5269768 Cheung Dec 1993 A
5270219 DeCastro et al. Dec 1993 A
5279576 Loo et al. Jan 1994 A
5288290 Brody Feb 1994 A
5312377 Dalton May 1994 A
5328474 Raines Jul 1994 A
5334163 Sinnett Aug 1994 A
5342346 Honda et al. Aug 1994 A
5344417 Wadsworth, Jr. Sep 1994 A
5350372 Ikeda et al. Sep 1994 A
5364387 Sweeney Nov 1994 A
5374264 Wadsworth, Jr. Dec 1994 A
5385547 Wong et al. Jan 1995 A
5445630 Richmond Aug 1995 A
5464123 Scarrow Nov 1995 A
5466219 Lynn et al. Nov 1995 A
5466220 Brenneman Nov 1995 A
5478337 Okamoto et al. Dec 1995 A
5492147 Challender et al. Feb 1996 A
5505714 Dassa et al. Apr 1996 A
5509433 Paradis Apr 1996 A
5520659 Hedges May 1996 A
5526853 McPhee et al. Jun 1996 A
5531695 Swisher Jul 1996 A
5566729 Grabenkort et al. Oct 1996 A
5569191 Meyer Oct 1996 A
5573281 Keller Nov 1996 A
5578015 Robb Nov 1996 A
5583052 Portnoff et al. Dec 1996 A
5584819 Kopfer Dec 1996 A
5591143 Trombley, III et al. Jan 1997 A
5607439 Yoon Mar 1997 A
5611576 Guala Mar 1997 A
5616203 Stevens Apr 1997 A
5636660 Pfleiderer et al. Jun 1997 A
5641010 Maier Jun 1997 A
5647845 Haber et al. Jul 1997 A
5651776 Appling et al. Jul 1997 A
5653686 Coulter et al. Aug 1997 A
5674195 Truthan Oct 1997 A
5718346 Weiler Feb 1998 A
D393722 Fangrow, Jr. et al. Apr 1998 S
5738144 Rogers Apr 1998 A
5743312 Pfeifer et al. Apr 1998 A
5746733 Capaccio et al. May 1998 A
5755696 Caizza May 1998 A
5772630 Ljungquist Jun 1998 A
5772652 Zielinski Jun 1998 A
RE35841 Frank et al. Jul 1998 E
5820621 Yale et al. Oct 1998 A
5827262 Neftel et al. Oct 1998 A
5832971 Yale et al. Nov 1998 A
5833213 Ryan Nov 1998 A
5834744 Risman Nov 1998 A
5873872 Thibault et al. Feb 1999 A
5879337 Kuracina et al. Mar 1999 A
5879345 Aneas Mar 1999 A
5887633 Yale et al. Mar 1999 A
5893397 Peterson et al. Apr 1999 A
5919182 Avallone Jul 1999 A
5944700 Nguyen et al. Aug 1999 A
5971965 Mayer Oct 1999 A
5989237 Fowles et al. Nov 1999 A
6003566 Thibault et al. Dec 1999 A
6004278 Botich et al. Dec 1999 A
6063068 Fowles et al. May 2000 A
D427308 Zinger Jun 2000 S
6080132 Cole et al. Jun 2000 A
6090093 Thibault et al. Jul 2000 A
6099511 Devos et al. Aug 2000 A
6113583 Fowles et al. Sep 2000 A
6139534 Niedospial, Jr. et al. Oct 2000 A
6142446 Leinsing Nov 2000 A
6156025 Niedospial, Jr. et al. Dec 2000 A
6159192 Fowles et al. Dec 2000 A
6174304 Weston Jan 2001 B1
6221041 Russo Apr 2001 B1
6221054 Martin et al. Apr 2001 B1
6238372 Zinger et al. May 2001 B1
6245044 Daw et al. Jun 2001 B1
D445501 Niedospial, Jr. Jul 2001 S
6280430 Neftel et al. Aug 2001 B1
6343629 Wessman et al. Feb 2002 B1
6348044 Coletti et al. Feb 2002 B1
6358236 DeFoggi et al. Mar 2002 B1
6379340 Zinger et al. Apr 2002 B1
6408897 Laurent et al. Jun 2002 B1
6409708 Wessman Jun 2002 B1
6474375 Spero et al. Nov 2002 B2
6478788 Aneas Nov 2002 B1
D468015 Horppu Dec 2002 S
6503240 Niedospial, Jr. et al. Jan 2003 B1
6503244 Hayman Jan 2003 B2
6524278 Campbell et al. Feb 2003 B1
D472316 Douglas et al. Mar 2003 S
6530903 Wang et al. Mar 2003 B2
D472630 Douglas et al. Apr 2003 S
6544246 Niedospial, Jr. Apr 2003 B1
6551299 Miyoshi et al. Apr 2003 B2
6558365 Zinger et al. May 2003 B2
6581593 Rubin et al. Jun 2003 B1
D483487 Harding et al. Dec 2003 S
D483869 Tran et al. Dec 2003 S
6656433 Sasso Dec 2003 B2
6666852 Niedospial, Jr. Dec 2003 B2
6681810 Weston Jan 2004 B2
6681946 Jansen et al. Jan 2004 B1
6699229 Zinger et al. Mar 2004 B2
6715520 Andreasson et al. Apr 2004 B2
6729370 Norton et al. May 2004 B2
6736798 Ohkubo et al. May 2004 B2
6745998 Doyle Jun 2004 B2
6752180 Delay Jun 2004 B2
D495416 Dimeo et al. Aug 2004 S
D496457 Prais et al. Sep 2004 S
6832994 Niedospial, Jr. et al. Dec 2004 B2
6852103 Fowles et al. Feb 2005 B2
6875203 Fowles et al. Apr 2005 B1
6875205 Leinsing Apr 2005 B2
6878131 Novacek et al. Apr 2005 B2
6890328 Fowles et al. May 2005 B2
6901975 Aramata et al. Jun 2005 B2
6949086 Ferguson et al. Sep 2005 B2
RE38996 Crawford et al. Feb 2006 E
6997917 Niedospial, Jr. et al. Feb 2006 B2
7024968 Raudabough et al. Apr 2006 B2
7074216 Fowles et al. Jul 2006 B2
7083600 Meloul Aug 2006 B2
7150735 Hickle Dec 2006 B2
7192423 Wong Mar 2007 B2
7294122 Kubo et al. Nov 2007 B2
D561348 Zinger et al. Feb 2008 S
7326194 Zinger et al. Feb 2008 B2
7350764 Raybuck Apr 2008 B2
7354422 Riesenberger et al. Apr 2008 B2
7354427 Fangrow Apr 2008 B2
7425209 Fowles et al. Sep 2008 B2
7435246 Zihlmann Oct 2008 B2
7452348 Hasegawa Nov 2008 B2
7470265 Brugger et al. Dec 2008 B2
7488297 Flaherty Feb 2009 B2
7491197 Jansen et al. Feb 2009 B2
7523967 Steppe Apr 2009 B2
D595420 Suzuki et al. Jun 2009 S
D595421 Suzuki et al. Jun 2009 S
7540865 Griffin et al. Jun 2009 B2
D595862 Suzuki et al. Jul 2009 S
D595863 Suzuki et al. Jul 2009 S
7611487 Woehr et al. Nov 2009 B2
7611502 Daly Nov 2009 B2
7632261 Zinger et al. Dec 2009 B2
7695445 Yuki Apr 2010 B2
7722090 Burton et al. May 2010 B2
D616984 Gilboa Jun 2010 S
7731678 Tennican et al. Jun 2010 B2
7743799 Mosler et al. Jun 2010 B2
7758082 Weigel et al. Jul 2010 B2
7771383 Truitt et al. Aug 2010 B2
7799009 Niedospial, Jr. et al. Sep 2010 B2
7803140 Fangrow, Jr. Sep 2010 B2
7879018 Zinger et al. Feb 2011 B2
20010029360 Miyoshi et al. Oct 2001 A1
20010051793 Weston Dec 2001 A1
20020017328 Loo Feb 2002 A1
20020087118 Reynolds et al. Jul 2002 A1
20020087141 Zinger et al. Jul 2002 A1
20020087144 Zinger et al. Jul 2002 A1
20020121496 Thiebault et al. Sep 2002 A1
20020123736 Fowles et al. Sep 2002 A1
20020127150 Sasso Sep 2002 A1
20020173752 Polzin Nov 2002 A1
20030036725 Lavi et al. Feb 2003 A1
20030100866 Reynolds May 2003 A1
20030120209 Jensen et al. Jun 2003 A1
20030153895 Leinsing Aug 2003 A1
20030195479 Kuracina et al. Oct 2003 A1
20030199846 Fowles et al. Oct 2003 A1
20030199847 Akerlund et al. Oct 2003 A1
20040044327 Hasegawa Mar 2004 A1
20040073189 Wyatt et al. Apr 2004 A1
20040153047 Blank et al. Aug 2004 A1
20040181192 Cuppy Sep 2004 A1
20040217315 Doyle Nov 2004 A1
20040236305 Jansen et al. Nov 2004 A1
20050148994 Leinsing Jul 2005 A1
20060030832 Niedospial et al. Feb 2006 A1
20060079834 Tennican et al. Apr 2006 A1
20060089603 Truitt et al. Apr 2006 A1
20060135948 Varma Jun 2006 A1
20060253084 Nordgren Nov 2006 A1
20070060904 Vedrine et al. Mar 2007 A1
20070083164 Barrelle et al. Apr 2007 A1
20070088252 Pestotnik et al. Apr 2007 A1
20070088293 Fangrow Apr 2007 A1
20070088313 Zinger et al. Apr 2007 A1
20070106244 Mosler et al. May 2007 A1
20070156112 Walsh Jul 2007 A1
20070167904 Zinger et al. Jul 2007 A1
20070191760 Iguchi et al. Aug 2007 A1
20070191764 Zihlmann Aug 2007 A1
20070191767 Hennessy et al. Aug 2007 A1
20070219483 Kitani et al. Sep 2007 A1
20070255202 Kitani et al. Nov 2007 A1
20070265574 Tennican et al. Nov 2007 A1
20070265581 Funamura et al. Nov 2007 A1
20070270778 Zinger et al. Nov 2007 A9
20070287953 Ziv et al. Dec 2007 A1
20080009789 Zinger et al. Jan 2008 A1
20080172024 Yow Jul 2008 A1
20080249479 Zinger et al. Oct 2008 A1
20090012492 Zihlmann Jan 2009 A1
20090054834 Zinger et al. Feb 2009 A1
20090082750 Denenburg et al. Mar 2009 A1
20090177177 Zinger et al. Jul 2009 A1
20090187140 Racz Jul 2009 A1
20090299325 Vedrine et al. Dec 2009 A1
20100010443 Morgan et al. Jan 2010 A1
20100030181 Helle et al. Feb 2010 A1
20100076397 Reed et al. Mar 2010 A1
20100087786 Zinger et al. Apr 2010 A1
20100228220 Zinger et al. Sep 2010 A1
20100312220 Kalitzki Dec 2010 A1
Foreign Referenced Citations (50)
Number Date Country
1913926 Sep 1970 DE
4122476 Jan 1993 DE
19504413 Aug 1996 DE
202004012714 Nov 2004 DE
0192661 Sep 1986 EP
0195018 Sep 1986 EP
0258913 Mar 1988 EP
0416454 Mar 1991 EP
0 521 460 Jan 1993 EP
0637443 Feb 1995 EP
0 518 397 Feb 1996 EP
0806597 Nov 1997 EP
0814866 Jan 1998 EP
0898951 Mar 1999 EP
1008337 Jun 2000 EP
1029526 Aug 2000 EP
1051988 Nov 2000 EP
1329210 Jul 2003 EP
1454609 Sep 2004 EP
1454650 Sep 2004 EP
1498097 Jan 2005 EP
1872824 Jan 2008 EP
2029242 Oct 1970 FR
2869795 Nov 2005 FR
1444210 Jul 1976 GB
4329954 Nov 1992 JP
11503627 Mar 1999 JP
9403373 Feb 1994 WO
9507066 Mar 1995 WO
9600053 Jan 1996 WO
9629113 Sep 1996 WO
9832411 Jul 1998 WO
9837854 Sep 1998 WO
0128490 Apr 2001 WO
0130425 May 2001 WO
0132524 May 2001 WO
0160311 Aug 2001 WO
0191693 Dec 2001 WO
0209797 Feb 2002 WO
03051423 Jun 2003 WO
2004041148 May 2004 WO
2005105014 Nov 2005 WO
2007015233 Feb 2007 WO
2007105221 Sep 2007 WO
2009029010 Mar 2009 WO
2009038860 Mar 2009 WO
2009040804 Apr 2009 WO
2009087572 Jul 2009 WO
2009093249 Jul 2009 WO
2009112489 Sep 2009 WO
Related Publications (1)
Number Date Country
20080009789 A1 Jan 2008 US
Provisional Applications (2)
Number Date Country
60587550 Jul 2004 US
60589568 Jul 2004 US